Literature DB >> 23408088

Consequential secondary structure alterations and aggregation during prolonged casein glycation.

Supriya Jindal1, Aabgeena Naeem.   

Abstract

Non-enzymatic glycosylation (glycation) of casein is a process used not just to ameliorate the quality of dairy products but also to increase the shelf life of canned foods, including baby milk supplements. Incubation of κ-casein with reducing sugars for 15 days at physiological temperature showed the formation of a molten globule state at day 9 and 12 during fructation and glucation respectively. This state exhibits substantial secondary structure and maximum ANS binding. Later on, glycation resulted in the formation of aggregates at day 12 in presence of fructose and day 15 in presence of glucose. Aggregates possess extensive β-sheet structure as revealed by far-UV CD and FTIR. These aggregates showed altered tryptophan environment, decrease ANS binding relative to molten globule state and increase in Thioflavin T fluorescence. Aggregates were also accompanied by the accumulation of AGEs, indicative of structural damage to the protein and formation of potentially harmful species at the physiological level. Fructose was more reactive than glucose and thus caused early and significant changes in the protein. From our studies, we conclude that controlling the extent of the Maillard reaction in the food industry is essential to counter its negative effects and expand its safety spectrum.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408088     DOI: 10.1007/s10895-013-1162-5

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  21 in total

1.  A conformational change in bovine beta-lactoglobulin at low pH.

Authors:  O E Mills; L K Creamer
Journal:  Biochim Biophys Acta       Date:  1975-02-27

Review 2.  Protein aggregation: more than just fibrils.

Authors:  Mark R H Krebs; Kristin R Domike; Athene M Donald
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

Review 3.  For protein misassembly, it's the "I" decade.

Authors:  R Wetzel
Journal:  Cell       Date:  1996-09-06       Impact factor: 41.582

4.  The solution structure of concanavalin A probed by FT-IR spectroscopy.

Authors:  J L Arrondo; N M Young; H H Mantsch
Journal:  Biochim Biophys Acta       Date:  1988-02-10

5.  1-anilino-8-naphthalene sulfonate as a protein conformational tightening agent.

Authors:  D Matulis; C G Baumann; V A Bloomfield; R E Lovrien
Journal:  Biopolymers       Date:  1999-05       Impact factor: 2.505

6.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

Authors:  Helen Vlassara; Weijing Cai; Jill Crandall; Teresia Goldberg; Robert Oberstein; Veronique Dardaine; Melpomeni Peppa; Elliot J Rayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

7.  Acetonitrile can promote formation of different structural intermediate states on aggregation pathway of immunoglobulin G from human and bovine.

Authors:  Samreen Amani; Aabgeena Naeem
Journal:  Int J Biol Macromol       Date:  2011-03-30       Impact factor: 6.953

8.  Characterization of a partially folded intermediate of papain induced by fluorinated alcohols at low pH.

Authors:  Aabgeena Naeem; Khursid Alam Khan; Rizwan Hasan Khan
Journal:  Arch Biochem Biophys       Date:  2004-12-01       Impact factor: 4.013

Review 9.  Protein fructosylation: fructose and the Maillard reaction.

Authors:  W L Dills
Journal:  Am J Clin Nutr       Date:  1993-11       Impact factor: 7.045

10.  Reexamination of the polymeric distributions of kappa-casein isolated from bovine milk.

Authors:  M L Groves; H J Dower; H M Farrell
Journal:  J Protein Chem       Date:  1992-02
View more
  1 in total

1.  Neo-Epitopes Generated on Hydroxyl Radical Modified GlycatedIgG Have Role in Immunopathology of Diabetes Type 2.

Authors:  Sidra Islam; Abdul Rouf Mir; Alok Raghav; Farzana Khan; Khursheed Alam; Asif Ali; Moin Uddin
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.